Investment Director / Bio-Partnering
Investment Strategy and Capital for Life-Sciences Companies
A partner of RBV Capital, Robert joint IAG in 2015 to contribute to strategic growth of the group and expand Bio-Partnering. He is heavily involved into building a diversified investment portfolio composed of early to market stage products. His interests are in biopharmaceuticals, biomedical technology and services, bioinformatics and healthcare IT, medical devices and innovative healthcare providers as well as cross-discipline companies.